Upcoming Investor Conferences for Novavax: Engage with the Future of Vaccines
Novavax's Participation in Key Investor Conferences
On February 27, 2025, Novavax, Inc. (Nasdaq: NVAX) announced its active participation in a series of upcoming investor conferences. These events serve as a platform for the management team to engage with investors and discuss the company's innovative approaches to tackling significant health challenges through vaccines.
Scheduled Conferences
1. TD Cowen 45th Annual Health Care Conference
- Date: March 4, 2025
- Time: 9:10 AM - 9:40 AM Eastern Time
- Location: Boston, MA
- Format: Fireside Chat
This conference will allow the management team to interact directly with potential investors and share insights into the company's strategies and future plans.
2. Leerink Partners 2025 Global Healthcare Conference
- Date: March 11, 2025
- Time: 3:40 PM - 4:10 PM ET
- Location: Miami Beach, FL
- Format: Presentation
In this session, Novavax aims to highlight its investment potential and progress in vaccine development, particularly its cutting-edge technology that leverages a protein-based nanoparticle and the Matrix-M™ adjuvant.
3. Jefferies Biotech on the Beach Summit
- Date: March 12, 2025
- Location: Miami Beach, FL
- Format: Investor Meetings
This summit represents a unique opportunity for Novavax to connect with key players in the biotech field, showcasing its innovation and strategic growth plans.
Webcast Availability
For those unable to attend in person, a webcast of the fireside chat and presentation will be accessible on the company's website, allowing investors to tune in remotely. Recordings of these sessions will be available for 30 days post-event.
About Novavax
Based in Gaithersburg, Maryland, Novavax is dedicated to addressing some of the world's most pressing health care challenges. The company focuses on developing innovative vaccines through advanced technology and partnerships. Their core expertise lies in infectious diseases, and they are progressively exploring opportunities in other health domains. By leveraging their development platform, Novavax is not only looking to expand its research pipeline but also seeking to create diverse partnerships that enhance its mission.
As Novavax continues to make strides in the vaccine sector, these conferences highlight its commitment to transparency and collaboration. Stakeholders are encouraged to follow Novavax's journey as it participates in discussions that could potentially shape the future of healthcare.
For further information and updates on the company's activities, visit Novavax's website or check their LinkedIn page.
For Media Inquiries
If you have any questions or need further information, you can reach out to:
Investors: Luis Sanay, CFA
Phone: 240-268-2022
Email: [email protected]
Media: Giovanna Chandler
Phone: 202-709-5563
Email: [email protected]
Through its strategic initiatives and innovative approach to biotechnology, Novavax aims to not only develop effective vaccines but also create a robust network of stakeholders that support its vision for improved global health.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.